Nestle India issues clarification: Why FMCG stock plunged? What's FSSAI baby formula row; why it matters to consumers?
Nestle India launched an initiative.
19 Sept 2026 · LiveMint Markets
FSSAI has launched three adjudication cases against Nestle India for compliance issues with its infant nutrition products. Despite recent stock pressure, Nestle maintained that its products comply with regulations and that all disclosures were timely made to the stock exchanges.
The analysis
Against that, the stock is +1.9% on the day at ₹1,321.80, and has returned -10.3% over three months. It sits 14% below its 52-week high. The fmcg sector has moved -9.8% over the same period, so Nestle India is running 0.5 points behind its peers.
For Nestle India, the question is how much of this is already reflected in the price and how much re-rates the fmcg peer set alongside it.
Market context
- The company directly in focus is NESTLEIND.
- Sector exposure: FMCG.
- The immediate tone of coverage reads negative.
In this story
Related coverage
Taking Stock: Market fails to hold on to day#39;s gains, ends marginally higher
Hindustan Unilever Q4 Preview: Price cuts, slow demand, regional competition to hurt topline
Dabur India’s Q2 growth is not inspiring. Will margin surprise lift investor confidence?
Market wrap: ITC, BSE, HCL Tech, Asian Paints top gainers and losers on Nifty and Sensex on Monday
Dabur shares rise 4% as firm sees double-digit Q2 growth; FMCG set for strong performance